FR2851469A1 - Composition et procede de soin contenant un inhibiteur de glucosidase - Google Patents
Composition et procede de soin contenant un inhibiteur de glucosidase Download PDFInfo
- Publication number
- FR2851469A1 FR2851469A1 FR0300625A FR0300625A FR2851469A1 FR 2851469 A1 FR2851469 A1 FR 2851469A1 FR 0300625 A FR0300625 A FR 0300625A FR 0300625 A FR0300625 A FR 0300625A FR 2851469 A1 FR2851469 A1 FR 2851469A1
- Authority
- FR
- France
- Prior art keywords
- dermatological
- glucosidase inhibitor
- cosmetic
- composition according
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102000004366 Glucosidases Human genes 0.000 title claims abstract description 18
- 108010056771 Glucosidases Proteins 0.000 title claims abstract description 18
- 239000003112 inhibitor Substances 0.000 title claims abstract description 9
- 239000000203 mixture Substances 0.000 title claims description 15
- 229940082892 tamarind seed extract Drugs 0.000 title claims description 3
- 206010040880 Skin irritation Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000036556 skin irritation Effects 0.000 title 1
- 231100000475 skin irritation Toxicity 0.000 title 1
- 230000000699 topical effect Effects 0.000 title 1
- 239000002537 cosmetic Substances 0.000 claims abstract description 10
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract description 8
- 239000000284 extract Substances 0.000 claims abstract description 6
- 235000004298 Tamarindus indica Nutrition 0.000 claims abstract description 4
- 244000269722 Thea sinensis Species 0.000 claims abstract description 4
- 240000004584 Tamarindus indica Species 0.000 claims abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract 2
- 239000004382 Amylase Substances 0.000 claims description 16
- 239000000419 plant extract Substances 0.000 claims description 12
- 102000013142 Amylases Human genes 0.000 claims description 10
- 108010065511 Amylases Proteins 0.000 claims description 10
- 235000019418 amylase Nutrition 0.000 claims description 10
- 230000002401 inhibitory effect Effects 0.000 claims description 9
- 239000008346 aqueous phase Substances 0.000 claims description 6
- 239000012071 phase Substances 0.000 claims description 6
- 239000013543 active substance Substances 0.000 claims description 4
- 201000004624 Dermatitis Diseases 0.000 claims description 3
- 208000009675 Perioral Dermatitis Diseases 0.000 claims description 3
- 239000013003 healing agent Substances 0.000 claims description 2
- 239000003906 humectant Substances 0.000 claims description 2
- 230000000887 hydrating effect Effects 0.000 claims description 2
- 238000003756 stirring Methods 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 9
- 229940122816 Amylase inhibitor Drugs 0.000 abstract 1
- 239000003392 amylase inhibitor Substances 0.000 abstract 1
- 230000010534 mechanism of action Effects 0.000 abstract 1
- 235000013311 vegetables Nutrition 0.000 abstract 1
- 238000011156 evaluation Methods 0.000 description 9
- 230000002255 enzymatic effect Effects 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 239000006071 cream Substances 0.000 description 5
- 239000000758 substrate Substances 0.000 description 4
- 229940062013 tamarind extract Drugs 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 238000002835 absorbance Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 210000003296 saliva Anatomy 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 229940092665 tea leaf extract Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229920001503 Glucan Polymers 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 241000596504 Tamarindus Species 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000000622 irritating effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- -1 soothing Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 description 1
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- BANXPJUEBPWEOT-UHFFFAOYSA-N isohexadecane Natural products CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 239000013643 reference control Substances 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- UEUYEWLWWIWPLC-UHFFFAOYSA-M sodium;2-[bis(2-hydroxyethyl)amino]ethanol;chloride Chemical compound [Na+].[Cl-].OCCN(CCO)CCO UEUYEWLWWIWPLC-UHFFFAOYSA-M 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/75—Anti-irritant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/74—Biological properties of particular ingredients
- A61K2800/78—Enzyme modulators, e.g. Enzyme agonists
- A61K2800/782—Enzyme inhibitors; Enzyme antagonists
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0300625A FR2851469B1 (fr) | 2003-01-14 | 2003-01-14 | Composition et procede de soin contenant un inhibiteur de glucosidase |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0300625A FR2851469B1 (fr) | 2003-01-14 | 2003-01-14 | Composition et procede de soin contenant un inhibiteur de glucosidase |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2851469A1 true FR2851469A1 (fr) | 2004-08-27 |
FR2851469B1 FR2851469B1 (fr) | 2007-09-21 |
Family
ID=32799433
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0300625A Expired - Lifetime FR2851469B1 (fr) | 2003-01-14 | 2003-01-14 | Composition et procede de soin contenant un inhibiteur de glucosidase |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR2851469B1 (fr) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009038875A1 (fr) * | 2007-09-18 | 2009-03-26 | Elc Management Llc | Compositions cosmétiques contenant des inhibiteurs de l'alpha-glucosidase et leurs procédés d'utilisation |
WO2011147768A1 (fr) * | 2010-05-24 | 2011-12-01 | Indena S.P.A. | Polysaccharide de graine de tamarin utilisé pour le traitement de maladies inflammatoires |
WO2011147767A1 (fr) * | 2010-05-24 | 2011-12-01 | Indena S.P.A. | Polysaccharide de graine de tamarin utilisé pour le traitement d'infections microbiennes |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07258105A (ja) * | 1994-03-24 | 1995-10-09 | Maruzen Pharmaceut Co Ltd | グルコシルトランスフェラーゼ阻害剤、口腔用剤および飲食物 |
JPH08231347A (ja) * | 1995-02-24 | 1996-09-10 | Maruzen Pharmaceut Co Ltd | ヒアルロニダーゼ阻害剤および化粧料 |
EP0815857A1 (fr) * | 1995-12-26 | 1998-01-07 | Suntory Limited | Agent anti-obesite dont le principe actif est la procyanidine |
US5876729A (en) * | 1995-01-03 | 1999-03-02 | Laboratoires Serobiologiques (Sa) | Use of extracts of tamarind seeds rich in xyloglycans and cosmetic or pharmaceutical product containing such extracts |
JP2001163795A (ja) * | 1999-12-07 | 2001-06-19 | Gunze Ltd | α−グルコシダーゼ阻害剤 |
JP2001206893A (ja) * | 1999-11-17 | 2001-07-31 | Sanpo Kk | 新規α−アミラーゼ阻害活性物質、その製造方法及びその用途 |
-
2003
- 2003-01-14 FR FR0300625A patent/FR2851469B1/fr not_active Expired - Lifetime
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH07258105A (ja) * | 1994-03-24 | 1995-10-09 | Maruzen Pharmaceut Co Ltd | グルコシルトランスフェラーゼ阻害剤、口腔用剤および飲食物 |
US5876729A (en) * | 1995-01-03 | 1999-03-02 | Laboratoires Serobiologiques (Sa) | Use of extracts of tamarind seeds rich in xyloglycans and cosmetic or pharmaceutical product containing such extracts |
JPH08231347A (ja) * | 1995-02-24 | 1996-09-10 | Maruzen Pharmaceut Co Ltd | ヒアルロニダーゼ阻害剤および化粧料 |
EP0815857A1 (fr) * | 1995-12-26 | 1998-01-07 | Suntory Limited | Agent anti-obesite dont le principe actif est la procyanidine |
JP2001206893A (ja) * | 1999-11-17 | 2001-07-31 | Sanpo Kk | 新規α−アミラーゼ阻害活性物質、その製造方法及びその用途 |
JP2001163795A (ja) * | 1999-12-07 | 2001-06-19 | Gunze Ltd | α−グルコシダーゼ阻害剤 |
Non-Patent Citations (4)
Title |
---|
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 02 29 February 1996 (1996-02-29) * |
PATENT ABSTRACTS OF JAPAN vol. 1997, no. 01 31 January 1997 (1997-01-31) * |
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 23 10 February 2001 (2001-02-10) * |
PATENT ABSTRACTS OF JAPAN vol. 2000, no. 24 11 May 2001 (2001-05-11) * |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009038875A1 (fr) * | 2007-09-18 | 2009-03-26 | Elc Management Llc | Compositions cosmétiques contenant des inhibiteurs de l'alpha-glucosidase et leurs procédés d'utilisation |
JP2010539174A (ja) * | 2007-09-18 | 2010-12-16 | イーエルシー マネージメント エルエルシー | αグルコシダーゼ阻害剤を含有する化粧用組成物及び使用方法 |
US9072717B2 (en) | 2007-09-18 | 2015-07-07 | Elc Management Llc | Cosmetic compositions containing alpha glucosidase inhibitors and methods of use |
WO2011147768A1 (fr) * | 2010-05-24 | 2011-12-01 | Indena S.P.A. | Polysaccharide de graine de tamarin utilisé pour le traitement de maladies inflammatoires |
WO2011147767A1 (fr) * | 2010-05-24 | 2011-12-01 | Indena S.P.A. | Polysaccharide de graine de tamarin utilisé pour le traitement d'infections microbiennes |
US10130652B2 (en) | 2010-05-24 | 2018-11-20 | Indena S.P.A. | Anti-inflammatory compositions |
US10206943B2 (en) | 2010-05-24 | 2019-02-19 | Indena S.P.A. | Antimicrobial compositions |
Also Published As
Publication number | Publication date |
---|---|
FR2851469B1 (fr) | 2007-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1776082A1 (fr) | Utilisation d'un hydrolysat de proteines de cruciferes en tant qu'agent depigmentant dans ou pour une composition cosmetique et/ou pharmaceutique | |
WO1995001159A1 (fr) | Composition antiacneique contenant un extrait de poria cocos wolf | |
EP4099975A1 (fr) | Procédé d'obtention d'un extrait aqueux de lavande, compositions comprenant un tel extrait et leurs utilisations cosmétiques | |
FR3022139A1 (fr) | Nouvelles compositions pour le traitement des rougeurs cutanees et de la rosacee | |
FR2746008A1 (fr) | Composition a usage topique anti-vieillissement | |
EP2046281B1 (fr) | Utilisation d'un extrait de graines de mimosa (d'acacia dealbta, d'acacia farnesiana ou d'acacia decurrens) dans une composition cosmetique | |
FR3051369B1 (fr) | Extraits de faine de hetre, compositions et utilisations | |
EP1722757B1 (fr) | Composition cosmetique amincissante comprenant en tant qu'agent actif un inhibiteur de metalloproteinases | |
EP3508195B1 (fr) | Extraits de racines de salvia miltiorrhiza et leur utilisation topique pour appaiser la peau | |
EP0954280B1 (fr) | Utilisation d'un extrait de terminalia catappa | |
FR2838340A1 (fr) | Utilisation d'un extrait d'algue brune dans les domaines cosmetique et dermatologique | |
FR2851469A1 (fr) | Composition et procede de soin contenant un inhibiteur de glucosidase | |
FR3055550B1 (fr) | Nouvel actif immunomodulateur et composition le comprenant | |
FR2902334A1 (fr) | Utilisation d'un extrait de souci dans une composition cosmetique. | |
FR3031458B1 (fr) | Extraits de salade, compositions et utilisations | |
FR2902335A1 (fr) | Utilisation d'un extrait de mimosa dans une composition cosmetique. | |
FR3111543A1 (fr) | Nouvelles utilisations d’un extrait de bois de rose | |
EP1461011B1 (fr) | Composition cosmetique pour lutter contre le vieillissement cutane | |
FR2914858A1 (fr) | Composition cosmetique | |
CN1189157C (zh) | 祛斑驻颜天然活性化妆品添加剂 | |
WO2023198519A1 (fr) | Extraits de fleurs de crocus sativus, compositions les comprenant et leurs utilisations dans les soins buccaux | |
WO2021209593A1 (fr) | Principe actif comprenant un extrait d'écorce de fruit immature de punica granatum et utilisations pour prevenir et/ou lutter contre l'acne | |
FR3031679A1 (fr) | Nouvel agoniste du recepteur vdr, analogue a la forme active de la vitamine d et mimetique du complexe calcitriol-vdr issu de la vigne | |
FR2834210A1 (fr) | Composition cosmetique pour lutter contre le vieillissement cutane | |
FR3087657A1 (fr) | Compositions cosmetiques ou nutraceutiques, contenant un extrait de primeveres |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
CL | Concession to grant licences | ||
AU | Other action affecting the ownership or exploitation of an industrial property right | ||
PLFP | Fee payment |
Year of fee payment: 14 |
|
PLFP | Fee payment |
Year of fee payment: 15 |
|
PLFP | Fee payment |
Year of fee payment: 16 |
|
PLFP | Fee payment |
Year of fee payment: 18 |
|
PLFP | Fee payment |
Year of fee payment: 19 |
|
PLFP | Fee payment |
Year of fee payment: 20 |
|
AU | Other action affecting the ownership or exploitation of an industrial property right |
Effective date: 20231016 |
|
CL | Concession to grant licences |
Name of requester: NAOS, FR Effective date: 20231016 Name of requester: NAOS INSTITUTE OF LIFE SCIENCE, FR Effective date: 20231016 Name of requester: LABORATOIRE BIODERMA, FR Effective date: 20231016 Name of requester: INSTITUT ESTHEDERM, FR Effective date: 20231016 |